Autoantibody-mediated neurological diseases

In 1672 Thomas Willis first described a patient with fatiguable muscle weakness, which is likely to have been myasthenia gravis (MG), a prototypic antibody-mediated neuroimmunological condition. However, the linking between MG and anti-acetylcholine receptor antibody only began 3 centuries later in the 1970s, a few years after discovering the antibody structure.Several clinical syndromes and autoantibodies of neuroimmunological disorders have been identified since, especially in the past two decades.
Source: Medicine - Category: Internal Medicine Authors: Tags: Clinical assessment in neurology Source Type: research